Ignite Creation Date:
2025-12-24 @ 2:35 PM
Ignite Modification Date:
2026-05-02 @ 12:08 PM
Study NCT ID:
NCT00044759
Status:
COMPLETED
Last Update Posted:
2007-10-10
First Post:
2002-09-04
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study Comparing the Safety and Efficacy of Piperacillin/Tazobactam to Cefepime in Patients With Hematologic Malignancy or Lymphoma
Sponsor:
Wyeth is now a wholly owned subsidiary of Pfizer
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
0910B1-308
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None